Bolt Biotherapeutics (BOLT) Other Working Capital Changes (2020 - 2026)
Bolt Biotherapeutics (BOLT) posted Other Working Capital Changes of $26000.0 for Q1 2026, up 2700.0% sequentially from -$1000.0 in Q4 2025, and down 80.3% YoY from $132000.0 in Q1 2025.
Bolt Biotherapeutics (BOLT) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Bolt Biotherapeutics has reported Other Working Capital Changes for 7 years, with the latest figure at $26000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 80.3% year-over-year to $26000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26000.0 (down 80.3% YoY) and the FY2025 annual result came in at $132000.0, up 406.98% from the prior year.
- Other Working Capital Changes advanced to $26000.0 in Q1 2026 per BOLT's latest filing, from -$1000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $2.7 million in Q3 2024 and troughed at -$4.9 million in Q2 2024.
- A 5-year average of -$247176.5 and a median of $67000.0 in 2025 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes slumped 8000.0% in 2022, then surged 406.98% in 2025.
- Over 5 years, Other Working Capital Changes stood at -$158000.0 in 2022, then surged by 100.63% to $1000.0 in 2023, then plunged by 4400.0% to -$43000.0 in 2024, then jumped by 97.67% to -$1000.0 in 2025, then soared by 2700.0% to $26000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered $26000.0, -$1000.0, and $1000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Bolt Biotherapeutics | 5.48 Mn | 5.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26,000.00 |
| Jun 30, 2026 | -26,000.00 |
| Jun 30, 2026 | -26,000.00 |
| Mar 31, 2026 | 26,000.00 |
| Mar 31, 2026 | 26,000.00 |
| Mar 31, 2026 | 26,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 132,000.00 |
| Mar 31, 2025 | 132,000.00 |
| Mar 31, 2025 | 132,000.00 |
| Mar 31, 2024 | -43,000.00 |
| Mar 31, 2024 | -43,000.00 |
| Mar 31, 2024 | -43,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |